BioLife4D Corporation (SAVU)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	32.31M
Revenue (ttm)	n/a
Net Income	-1.96M
EPS	-0.38
Shares Out	5.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SAVU

BioLife4D Corporation is a pioneering biotech company that plans to leverage current advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation – potentially lifesaving technology that ultimately gives patients the gift of time. We are committed to perfecting the technology to make viable organ replacement an accessible and affordable reality, as well as mini-hearts for cardiotoxicity testing. We believe that our groundbreaking approach converges recent breakthroughs in regenerative medicine, adult ...

• Industry: Health Care
• Sector: Biotechnology
• Founded: 2016
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: SAVU
• Website: https://biolife4d.com/

Financial Performance

Data Source: SEC filings Last updated: Sep 4, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error